Pre-Transplant Rituximab Is Associated with a Greatly Reduced Risk of Epstein-Barr Virus Reactivation Following Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Burns, David [1 ]
Rana, Shabeeha [2 ]
Howman, Andrew [3 ]
Nagra, Sandeep [1 ]
Ward, Janice [1 ]
Osman, Husam [4 ]
Taha, Yusri [5 ,6 ]
Byrne, Jenny [2 ]
Das-Gupta, Emma [2 ]
Raghavan, Manoj [1 ]
Malladi, Ram [1 ]
Cook, Mark [1 ]
Mahendra, Prem [1 ]
Russell, Nigel H. [2 ]
Craddock, Charles [1 ]
Fox, Christopher [2 ]
Chaganti, Sridhar [1 ]
机构：
[1] Univ Hosp Birmingham NHS Trust, Ctr Clin Haematol, Birmingham, W Midlands, England
[2] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England
[3] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[4] Birmingham Heartlands Hosp, Hlth Protect Agcy Lab, Birmingham B9 5ST, W Midlands, England
[5] Nottingham Univ Hosp NHS Trust, Dept Virol, Nottingham, England
[6] Nottingham Univ Hosp NHS Trust, Dept Infect Dis, Nottingham, England
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.460.460
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
460
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem cell transplantation
    Ahmad, Imran
    Kwan, John
    Meuleman, Nathalie
    Lewalle, Philippe
    Crokaert, Francoise
    Bron, Dominique
    BLOOD, 2007, 110 (11) : 328B - 328B
  • [32] Spectrum of Epstein-Barr Virus-Associated Diseases in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation
    Xuan, Li
    Jiang, Xinmiao
    Sun, Jing
    Zhang, Yu
    Huang, Fen
    Fan, Zhiping
    Guo, Xutao
    Dai, Min
    Liu, Can
    Yu, Guopan
    Zhang, Xian
    Wu, Meiqing
    Huang, Xiaojun
    Liu, Qifa
    TRANSPLANTATION, 2013, 96 (06) : 560 - 566
  • [33] Epstein-Barr virus-associated posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation
    Sanz, Jaime
    Andreu, Rafael
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (06) : 677 - 683
  • [34] Guillain-Barre sindrome within Epstein-Barr virus reactivation after allogeneic haematopoietic stem cell transplantation
    Baldini, S.
    Nozzoli, C.
    Gozzini, A.
    Bartolozzi, B.
    Guidi, S.
    Bosi, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S215 - S216
  • [35] The efficacy and safety of rituximab in treatment of Epstein-Barr virus disease post allogeneic hematopoietic stem-cell transplantation
    许兰平
    ChinaMedicalAbstracts(InternalMedicine), 2013, 30 (01) : 58 - 58
  • [36] Epstein-Barr virus in paediatric stem cell transplantation
    Staehelin, F
    Beutler, D
    Avoledo, P
    Gratwohl, A
    Kühne, T
    BONE MARROW TRANSPLANTATION, 2004, 33 : S229 - S229
  • [37] Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation
    Xiu-li Wu
    Qi-fa Liu
    Journal of Hematology & Oncology, 5 (Suppl 1)
  • [38] Epstein-Barr virus driven lymphoproliferative disorders post allogeneic stem cell transplantation
    Lavin, M.
    Crowley, B.
    Browne, P. V.
    Flynn, C.
    Hayden, P.
    Vandenberghe, E.
    O'Neill, G.
    Conneally, E.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S143 - S143
  • [39] Novel Risk Factors for Epstein-Barr Virus (EBV) Reactivation and Post-Transplant Lymphoproliferative Disorder (PTLD) after Allogeneic Hematopoietic Stem Cell Transplant
    Rodriguez, Lizamarie Bachier
    Shore, Tsiporah B.
    Gergis, Usama
    Hsu, Jingmei
    Phillips, Adrienne A.
    Mayer, Sebastian A.
    Rennert, Hanna
    Van Besien, Koen
    BLOOD, 2017, 130
  • [40] Transplantation of solid organ recipients shedding Epstein-Barr virus DNA pre-transplant: A prospective study
    Verghese, Priya S.
    Schmeling, David O.
    Filtz, Emma A.
    Grimm, Jennifer M.
    Matas, Arthur J.
    Balfour, Henry H.
    CLINICAL TRANSPLANTATION, 2017, 31 (11)
12345